These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8193521)

  • 61. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
    Khan NA; McAlister FA; Rabkin SW; Padwal R; Feldman RD; Campbell NR; Leiter LA; Lewanczuk RZ; Schiffrin EL; Hill MD; Arnold M; Moe G; Campbell TS; Herbert C; Milot A; Stone JA; Burgess E; Hemmelgarn B; Jones C; Larochelle P; Ogilvie RI; Houlden R; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Dechamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Tobe S; Touyz RM;
    Can J Cardiol; 2006 May; 22(7):583-93. PubMed ID: 16755313
    [TBL] [Abstract][Full Text] [Related]  

  • 62. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapy.
    Sowers JR
    Am Heart J; 1991 Sep; 122(3 Pt 2):932-5. PubMed ID: 1877473
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential effects of antihypertensive drugs on hypertension: associated risk factors.
    Weidmann P
    Cardiology; 1994; 85 Suppl 1():78-83. PubMed ID: 7743540
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Beyond blood pressure control. Effect of antihypertensive therapy on cardiovascular risk factors.
    Maxwell MH
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):366S-371S. PubMed ID: 3056446
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
    Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
    J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coronary heart disease and hypertension.
    Weber MA
    Am J Hypertens; 1994 Oct; 7(10 Pt 2):146S-153S. PubMed ID: 7826565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Guidelines for the management of hypertension at primary health care level. Hypertension Society of Southern Africa, endorsed by the Medical Association of South Africa and the Medical Research Council.
    S Afr Med J; 1995 Dec; 85(12 Pt 2):1321-5. PubMed ID: 8600604
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulin resistance and hypertension.
    Passa P
    Clin Exp Hypertens; 1993 Nov; 15(6):1047-59. PubMed ID: 8268872
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolic considerations in the choice of therapy for the patient with hypertension.
    Black HR
    Am Heart J; 1991 Feb; 121(2 Pt 2):707-15. PubMed ID: 1671190
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Elevated heart rate: a major risk factor for cardiovascular disease.
    Palatini P; Julius S
    Clin Exp Hypertens; 2004; 26(7-8):637-44. PubMed ID: 15702618
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pleasurable behaviors reduce stress via brain reward pathways.
    Ulrich-Lai YM; Christiansen AM; Ostrander MM; Jones AA; Jones KR; Choi DC; Krause EG; Evanson NK; Furay AR; Davis JF; Solomon MB; de Kloet AD; Tamashiro KL; Sakai RR; Seeley RJ; Woods SC; Herman JP
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20529-34. PubMed ID: 21059919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.